● WEEKEND | NEXT OPEN: 2026-09-14 09:30 ET | 08:17 ET | PRICES DELAYED 15 MIN | NYSE · NASDAQ · TSX

FLESH-EATING WORM MIGRATION = ZTS Moon πŸŒ‘

BULLISH by u/MagicMakiii | Jun 04, 2026 | 1↑ 0 comments | 29 views | VIEW ON REDDIT
$ZTS
$ZTS ZOETIS INC. HEALTHCARE EQUITY SIMULATION
$77.34
+2.32 (+3.09%)
LAST PRICE Β· 15 MIN DELAY
DAY CHG +3.09%
5D CHG -0.50%
30D CHG +3.30%
AI SUMMARY β€” The New World Screwworm parasite has returned to the US after decades of eradication, creating a potential massive market for livestock treatments. Zoetis (ZTS) is positioned as the primary supplier of parasiticide treatments, potentially capturing significant agricultural spending as ranchers combat herd losses.
TICKERZTS USERu/MagicMakiii
RATING BULLISH ENTRY $77.59
POSITION 128 sh SYN BOOK VAL $9931.52
CURRENT $77.34 P&L % -0.32%
CURR VAL $9899.52 P&L $ -32.00

I just found some nightmare fuel that could print absolute bank.

The USDA just confirmed the New World Screwworm is officially back in the United States.

DD:

What is it? It’s a flesh-eating parasitic fly that lays its eggs in the wounds of cattle.
Why is it bad? Unlike normal maggots, these larvae exclusively eat living tissue, often resulting in massive, easily infected gaping wounds.
How did it get here? The US originally eradicated this parasite back in the 1960s by releasing sterile male flies, successfully pushing the species down to the Darien Gap where a border was maintained for decades. Now, thanks to illegal cattle trading and cocaine smuggling, they've breached the border and are making a comeback.
Why Zoetis (ZTS) Will Moon:
When ranchers see their herds getting eaten alive by parasitic maggots, they are going to panic-buy livestock medicines and parasiticides. Enter Zoetis (ZTS).
The estimated cost savings for eradicating this parasite was around 900 million dollars annually since the 1960s, which means the agricultural sector is going to have to spend a massive amount of capital fighting it again.

Here is the absolute kicker: Zoetis is the only firm in the market offering treatment for this. They have a complete monopoly on saving these herds, positioning them perfectly to supply the chemical artillery and rake in the cash.

Current Stock Performance:
Zoetis is beaten down due to its recent slowdown but this catalyst is exactly what it needs to get some momentum.

The market hasn't priced in the flesh-eating worm catalyst yet, nor do they realize ZTS holds the monopoly on the cure. This looks like the dip-buying opportunity before the mainstream media catches on.